Final Guidance Seeks to Speed Interchangeable Biosimilars to Market

Drug Industry Daily
A A
The FDA on Friday released a final interchangeability guidance that regulators hope will help speed cheaper biosimilars to patients who need them desperately.

To View This Article:

Login

Subscribe To Drug Industry Daily